Follow-up for 5 years after percutaneous coronary intervention and coronary artery bypass grafting in patients with coronary multivessel lesions of coronary heart disease complicating type 2 diabetes mellitus
WU Yun-tao
TIAN Guo-xiang
ZHANG Wei
XIA Chang-quan
WANG Xiao-bing
YAO Lu
LI Xiang
ZHANG Xiao-dong
SUN Yan-ming
GAO Ying-chun
Abstract：Objective To compare the long-term curative effects between implanting drug eluting stent (DES) during percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in patients with coronary multivessel lesions of coronary heart disease (CHD) complicating type 2 diabetes mellitus (T2DM). Methods The patients with successful selective revascularization were chosen continuously from Dec. 2002 to Dec. 2008, and divided into CABG group (n=270) and DES group (n=285). All patients were followed up for 5 years from 30 d after the operation to the 5th year. The content of follow-up included major adverse cardiovascular events (MACE), such as all-cause mortality, cardiac death, non-fatal stroke, non-fatal myocardial infarction, angina recurrence and onemore revascularization.Results The follow-up rate was 100% in all patients. In 2 groups, 5-year all-cause mortality (1.11%vs. 1.40%), rate of cardiac death (0% vs. 0%) and incidence of non-fatal stroke (2.22%vs. 2.81%) had no statistical difference (P>0.05). In DES group, incidence of non-fatal myocardial infarction (3.15%), angina recurrent rate (17.89%) and onemore revascularization rate (12.28%) were higher than those in CABG group (1.11, 5.56%, 0.74%, andP<0.05~P<0.01).Conclusion CABG and PCI have no significant difference in 5-year survival rate in patients with coronary multivessel lesions of CHD complicating T2DM, while long-term angina recurrent rate, onemore revascularization rate and incidence of non-fatal myocardial infarction are higher in DES group than those in CABG group.
Keywords：Coronary heart diseaseType 2 diabetes mellitusCoronary artery bypass graftingPercutaneous coronary interventionCoronary multivessel lesionsDrug eluting stent
Publication Date：2014-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 683-686 )